Leerink Swann Raises PT on Santarus (SNTS)

Article Related Press Releases (1) Related Articles (2) Stock Quotes (1) Comments (0)

Leerink Swann today reiterated an Outperform on Santarus (NASDAQ: SNTS) and raised its price target to $17 to $18 (from $15 to $16). Yesterday Santarus reported Q4 results.

Commenting on the news, analyst Jason M. Gerberry said, "We are encouraged by the strength of Zegerid---which had higher-than-expected AG volume & pricing---and mgmt's positive commentary on the launch of Uceris---initial feedback from managed care plans has been positive noting pricing is viewed favorably in context of other second line options such as biologic therapy, and mgmt is less concerned about prior authorizations."

For an analyst ratings summary and ratings history on Santarus (NASDAQ: SNTS) click here. For more ratings news on Santarus click here.

Shares of Santarus closed at $13.80 yesterday, with a 52 week range of $4.65-$13.80.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
• Signs of Solid Q2 at American Eagle (AEO) - Analyst
• Deutsche Bank Raises PT on NetApp (NTAP) to $48

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?